Maintenance PARP inhibitor therapy: is maintaining quality of life enough?

被引：2

作者：

Bouberhan, Sara ^{[1
]}

Shea, Meghan ^{[1
]}

Cannistra, Stephen A. ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Program Gynecol Med Oncol, Boston, MA 02215 USA

来源：

LANCET ONCOLOGY | 2018年 / 19卷 / 10期

关键词：

OVARIAN-CANCER;

D O I：

10.1016/S1470-2045(18)30623-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：E504 / E504

页数：1

相关论文

共 4 条

[1] Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial [J].

Friedlander, Michael ;

Gebski, Val ;

Gibbs, Emma ;

Davies, Lucy ;

Bloomfield, Ralph ;

Hilpert, Felix ;

Wenzel, Lari B. ;

Eek, Daniel ;

Rodrigues, Manuel ;

Clamp, Andrew ;

Penson, Richard T. ;

Provencher, Diane ;

Korach, Jacob ;

Huzarski, Tomasz ;

Vidal, Laura ;

Salutari, Vanda ;

Scott, Clare ;

Nicoletto, Maria Ornella ;

Tamura, Kenji ;

Espinoza, David ;

Joly, Florence ;

Pujade-Lauraine, Eric .

LANCET ONCOLOGY, 2018, 19 (08) :1126-1134

[2] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer [J].

Mirza, M. R. ;

Monk, B. J. ;

Herrstedt, J. ;

Oza, A. M. ;

Mahner, S. ;

Redondo, A. ;

Fabbro, M. ;

Ledermann, J. A. ;

Lorusso, D. ;

Vergote, I. ;

Ben-Baruch, N. E. ;

Marth, C. ;

Madry, R. ;

Christensen, R. D. ;

Berek, J. S. ;

Dorum, A. ;

Tinker, A. V. ;

du Bois, A. ;

Gonzalez-Martin, A. ;

Follana, P. ;

Benigno, B. ;

Rosenberg, P. ;

Gilbert, L. ;

Rimel, B. J. ;

Buscema, J. ;

Balser, J. P. ;

Agarwal, S. ;

Matulonis, U. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) :2154-2164

[3] Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial [J].

Oza, Amit M. ;

Matulonis, Ursula A. ;

Malander, Susanne ;

Hudgens, Stacie ;

Sehouli, Jalid ;

del Campo, Josep M. ;

Berton-Rigaud, Dominique ;

Banerjee, Susana ;

Scambia, Giovanni ;

Berek, Jonathan S. ;

Lund, Bente ;

Tinker, Anna V. ;

Hilpert, Felix ;

Palacio Vazquez, Isabel ;

D'Hondt, Veronique ;

Benigno, Benedict ;

Provencher, Diane ;

Buscema, Joseph ;

Agarwal, Shefali ;

Mirza, Mansoor R. .

LANCET ONCOLOGY, 2018, 19 (08) :1117-1125

[4] Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial [J].

Pujade-Lauraine, Eric ;

Ledermann, Jonathan A. ;

Selle, Frederic ;

Gebski, Val ;

Penson, Richard T. ;

Oza, Amit M. ;

Korach, Jacob ;

Huzarski, Tomasz ;

Poveda, Andres ;

Pignata, Sandro ;

Friedlander, Michael ;

Colombo, Nicoletta ;

Harter, Philipp ;

Fujiwara, Keiichi ;

Ray-Coquard, Isabelle ;

Banerjee, Susana ;

Liu, Joyce ;

Lowe, Elizabeth S. ;

Bloomfield, Ralph ;

Pautier, Patricia .

LANCET ONCOLOGY, 2017, 18 (09) :1274-1284